Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia
Thrombosis and Haemostasis · 01.03.2025 · 125 (03) · 218-229
DOI: 10.1055/a-2225-5263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2025. Verfasst von Yicong Ye und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing Anzhen Hospital, Beijing, C…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome, Thrombocytopenia. Die Arbeit nennt 26 Literaturangaben. Gefördert von: A collaborative programme of the American Heart Association and the Chinese Society of Cardiology, Collaborative program of the American Heart Association and the Chinese Society of Cardiology.
Abstract (Originalsprache)
Background
Baseline thrombocytopenia is commonly observed in patients with acute coronary syndrome (ACS) requiring percutaneous coronary intervention (PCI).
Aim
The purpose of this analysis was to investigate safety and effectiveness of PCI in ACS patients with baseline mild-to-moderate thrombocytopenia.
Methods
The data were collected from the Improving Care for Cardiovascular Disease in China–Acute Coronary Syndrome project. A total of 50,009 ACS patients were recruited between July 2017 and December 2019. Among them, there were 6,413 patients with mild-to-moderate thrombocytopenia, defined as a platelet count of ≥50 × 109/L and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing Anzhen Hospital, Beijing, China.
- Department of Epidemiology, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing Anzhen Hospital, Beijing, China.
- Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, United States.
- Department of Cardiology, Peking University First Hospital, Beijing, China.
- Division of Cardiology, Geffen School of Medicine at University of California, Los Angeles, California, United States.
- Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Fudan University, Zhongshan Hospital, Shanghai, China.
Förderung
- A collaborative programme of the American Heart Association and the Chinese Society of Cardiology
- Collaborative program of the American Heart Association and the Chinese Society of Cardiology
Zitieren
APA
Ye, Y., Hao, Y., Zhao, X., Liu, J., Yang, N., Smith, S. C., Huo, Y., Fonarow, G. C., Ge, J., Morgan, L., Sun, Z., Hu, D., Yang, Y., Ma, C. S., Zhao, D., Han, Y., Liu, J., & Zeng, Y. (2025). Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia. Thrombosis and Haemostasis, 125(03), 218-229. https://doi.org/10.1055/a-2225-5263
Vancouver
Ye Y, Hao Y, Zhao X, Liu J, Yang N, Smith SC, et al. Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia. Thrombosis and Haemostasis. 2025;125(03):218-229. doi:10.1055/a-2225-5263
BibTeX
@article{Ye2025,
author = {Ye, Yicong and Hao, Yongchen and Zhao, Xiliang and Liu, Jun and Yang, Na and Smith, Sidney C and Huo, Yong and Fonarow, Gregg C and Ge, Junbo and Morgan, Louise and Sun, Zhaoqing and Hu, Danqing and Yang, Yiqian and Ma, Chang-Sheng and Zhao, Dong and Han, Yaling and Liu, Jing and Zeng, Yong},
title = {Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {03},
pages = {218--229},
doi = {10.1055/a-2225-5263}
}
EUVIMED